According to sources, China is getting close to announcing a revised National Reimbursement Drug List, the group of drugs covered by China's national insurance plan. 130 will be chemical drugs and the rest will be traditional Chinese medicines.
I hope my screed last week about frothy dry bulk carrier stocks persuaded you not to get into that thicket—or to sell out if you had been lured in. The group, led by Dryships, which we sold ages ago, duly crashed.
The global repricing of inflation expectations continues at a feverish pace in the aftermath of the Trump victory, leading to another surge in US equity futures, up 15 points or 0.7% to 2175, with Asian and European stock market all jumping.
Wednesday, September 21, 2016 11:31 AM EST
AstraZeneca announced its decision to withdraw the Marketing Authorization Application submitted to the European Medicines Agency's Committee for Medicinal Products for Human Use in June 2015 for cediranib.